Research published in the journal Nature Communications describes distribution of a DNA defect in the glioblastoma genome and its relationship with patient survival.
Post Tagged with: "brain cancer"
Seattle Times – Quotes David Roberts, professor of surgery and neurology, on news that Seattle Children’s Hospital will be testing a new dye derived from scorpion venom that lights up cancer cells so surgeons can see — and remove — deadly brain tumors. Roberts and other colleagues have also been testing a similar drug compound, 5-aminolevulinic acid (5-ALA), which targets glial tumors.
A neuro-oncology research team at Dartmouth’s Norris Cotton Cancer Center, led by the Director Mark A. Israel, MD with first author Gilbert J. Rahme, PhD, recently identified the transcription factor Id4 as a suppressor of tumor cell invasion in glioblastoma.